Navigation Links
DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
Date:6/23/2008

EL SEGUNDO, Calif., June 23 /PRNewswire/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney failure and disease (CKD), recently introduced its EMPOWER program, a series of free community-based workshops that encourage CKD patients to take control of their health and make informed decisions about their dialysis care.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

Available in more than 40 locations throughout the U.S. and led by a team of DaVita(R) nurses, renal dietitians and social workers, EMPOWER uses a multidisciplinary approach to educate CKD patients about their disease, delaying its progression and the different treatment options available. Workshops also focus on preparing patients for life on dialysis, or a kidney transplant if needed.

The program's goal is to impact the lives of the more than eight million Americans living with Stage 3 and 4 CKD. To date, DaVita has also reached out to more than 100,000 Americans through its Kidney Education and You(R) program, which offers health education seminars and useful tools to help prevent kidney disease brought on by risk factors like diabetes and high blood pressure.

"Education is one of the most powerful ways to help people with CKD," says Dori Schatell, MS, executive director of the non-profit Medical Education Institute. "Two different research groups have found that education is even more effective than nephrologist referral at slowing the progression of CKD, ensuring a planned (rather than emergent) dialysis start and even improving survival. The more opportunities patients have to learn about kidney disease, the better they can care for themselves -- and make treatment choices that will fit their lives and enable them to keep their jobs or continue other activities that are meaningful to them."

Workshops are stage-spec
'/>"/>

SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DaVita Clinical Research Completes Record Number of Renal Trials in 2007
2. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
3. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
4. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
5. Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
6. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
7. Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
8. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
9. CherryPharm First All-Natural Food to Improve Sleep
10. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
11. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),...rminimallydisruptivesurgicaltreatmentsforthespine,...y,November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfe...sementfortheCompany,sproductsandwillincludecomment...ssion.Thedial-innumbersare1-877-407-4018fordomesti...
(Date:11/25/2009)...dSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareInt...ovatorandprovideroflessinvasive,miniaturizedcircul...tofadvancedheartfailure,todayannouncedthatitissche...perJaffrayHealthCareConferenceat8:00amESTonWednesd...YorkPalaceHotel,December1-2. ,, Alivewebcastoft...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--QuestDiagnosticsIncorpora...tictesting,informationandservices,announcedthatiti...careConferenceinNewYorkCity.Thepresentationissched...me. ,, Duringtheconference,thecompanywillreaffi...peratingincometoexceed18%ofrevenues,anddilutedearn...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 1Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 2Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 14 2009 56735 1NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 1NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 2NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 3NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 4
...ls that multiply and migrate in the, embryo to giv... a finding, that suggests that these cells might ...n., Oct. 3 Investigators at St.,Jude Children,s R...he,origin of the mammalian lymphatic vasculature -...to various essential housekeeping functions in the...
...maceuticals, Inc. (Nasdaq: TPPH ) announced today...i-center study of TPI 287 in patients with,advance...ial exploring the,activity of TPI 287 in various t...this year in advanced hormone refractory prostate ...oved for pancreatic cancer and,effective treatment...
Other Medicine Technology:St. Jude Settles Century-Old Debate on Origin of Mammalian Network of Lymphatic Vessels 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5
(Date:11/26/2009)...unications announces a highly effective and unconv...ggling to make an economic recovery. , ...rs is the type of challenge that could send ailing... Dr. David Benton, business growth expert and auth...dash; The Rfactor Intensive . “Fear is on...
(Date:11/25/2009)...ire/--TheBartleHallConventionCenterwilltemporarily...enKansasCityhoststhelatestinaseriesofmassivefreecl...thasthepotentialtobethebiggestoneyet,becauseitwill...ysinsteadofoveraweekend,"SheriWood,executivedirect...NationalAssociationofFreeClinics(NAFC). ,, Atpr...
(Date:11/25/2009)...ntinelleMedicalInc.,aleadingmanufacturerofbreastMR...teofnewleadingedgeclinicalapplicationsonitsAegis(T...ogicalSocietyofNorthAmerica(RSNA)annualmeetinginCh...ationsleveragetheuniquehighqualityimagesgeneratedb...ultipleimagingmodalitiesformulti-parametricassessm...
(Date:11/25/2009)...USNewswire/--TheBlackAIDSInstituterecentlyheldBoar...for2010. ,, ThenewBoardMembersareahighlydiverse...nance,governmenthealthprograms,editorial,andbusine...ofpersonalbackgroundsincludingbothheterosexualandg...representingmultipleagegroups. ,, (Photo: http:...
(Date:11/25/2009)...ancer who were treated with cisplatin-based chemot...rological side effects and Raynaud-like phenomena,...according to a new study published online November...te . , Marianne Brydy, M.D., of the Department o...en, Norway, and colleagues conducted a cross-secti...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...ology says that it is possible to reduce high bloo... Scientists, in an attempt to study the effects of...lar responses, had found out the result from the r...lectro-puncture. Acupuncture is one of the t...
... laproscopic surgery, may require the use of a pul...ays a study published in the new issue of Archives...hat has a genetic component and often gets magnifi...ne of the most common procedures to control morbid...
... inner ear may restore partial hearing ability of ...n Nature Medicine. Scientists are of the ... regulatory gene called Atoh1 can be used to encou...cells of the inner ear are encouraged to change th...
...lic Health had found out that the intake of vitami...erosis (MS) in women. The study said that women wh...e of developing MS than the ones who did not take ...odern day treatment may slow the course of develop...
...like keratitis by wearing the latest silicone hydr...rnal// of Ophthalmology. Scientists showed th...ar or extended wear contact lenses have varied res...tudy and had used a clinical severity matrix to di...
...cer patients and people without liver cancer found...developing liver cancer compared to the general po...nt, such as demographics and major risk factors fo...cancer, may be boosting the risk even further. ...
Other Medicine News:
CRP FULL RANGE (0.1-160 mg/l)
Uric Acid (UA)
Apolipoprotein B (undiluted sample) Liquid
Urea (Kinetic) 3 minute read
Medicine Products: